Key result
Omega-conotoxin GVIA (0.3-3 nmol) attenuated atrial contractile force in a dose-dependent manner without affecting sinus rate in isolated, blood-perfused dog right atria.
Why the study?
Does omega-conotoxin GVIA affect atrial contractile force and sinus rate in isolated canine atria?
Does omega-conotoxin GVIA affect atrial contractile force and sinus rate in isolated canine atria?
Answers are grounded in this paper and cite their sources.
Omega-conotoxin GVIA, an N-type calcium channel blocker, depresses atrial contractility without affecting pacemaker activity in a canine model.
Using an isolated, blood-perfused canine atrial preparation, we investigated the effects of omega-conotoxin GVIA (omega-CgTX), a blocker of N-type voltage-operated calcium channels, on the atrial contractile force and sinus rate. Omega-CgTX in a dose range of 0.3-3 nmol gradually attenuated the atrial contractile force in a dose-dependent manner, but did not affect the sinus rate, indicating that it can depress contractility but not pacemaker activity.
No takes yet. Share an insight, caveat, or question.
Ren et al. (1991) studied this question. omega-conotoxin GVIA was evaluated on atrial contractile force and sinus rate. Omega-conotoxin GVIA (0.3-3 nmol) attenuated atrial contractile force in a dose-dependent manner without affecting sinus rate in isolated, blood-perfused dog right atria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: